Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant
Jorge Camacho, Estela Giménez, Eliseo Albert, Joao Zulaica, Beatriz Álvarez-Rodríguez, Ignacio Torres, Luciana Rusu, Javier S. Burgos, Salvador Peiró, Hermelinda Vanaclocha, Ramón Limón, María Jesús Alcaraz, View ORCID ProfileJosé Sánchez-Payá, Javier Díez-Domingo, View ORCID ProfileIñaki Comas, Fernando Gonzáles-Candelas, View ORCID ProfileRon Geller, David Navarro the Valencian Vaccine Research Program (ProVaVac) study group
doi: https://doi.org/10.1101/2022.07.19.22277747
Jorge Camacho
1Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
b PharmEstela Giménez
1Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
PhDEliseo Albert
1Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
PhDJoao Zulaica
2Institute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, 46980, Valencia, Spain
PhDBeatriz Álvarez-Rodríguez
2Institute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, 46980, Valencia, Spain
PhDIgnacio Torres
1Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
PhDLuciana Rusu
2Institute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, 46980, Valencia, Spain
PhDJavier S. Burgos
3General Directorate of Research and Healthcare Supervision, Department of Health, Valencia Government, Valencia, Spain
MDSalvador Peiró
4Foundation for the promotion of health and biomedical research of the Valencian Community (FISABIO), Valencia, Spain
MDHermelinda Vanaclocha
5General Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain
MDRamón Limón
6General Directorate of Healthcare. Department of Health, Valencian Government, Valencia, Spain
MDMaría Jesús Alcaraz
1Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
MDJosé Sánchez-Payá
7Preventive Medicine Service, Alicante General and University Hospital, Alicante, Spain
8Alicante Institute of Health and Biomedical Research (ISABIAL), Alicante, Spain
MDJavier Díez-Domingo
4Foundation for the promotion of health and biomedical research of the Valencian Community (FISABIO), Valencia, Spain
MDIñaki Comas
9Biomedicine Institute of Valencia, Spanish Research Council (CSIC)
10CIBER in Epidemiology and Public Health, Spain; Joint Research Unit “Infection and Public Health” FISABIO-University of Valencia, Valencia, Spain
PhDFernando Gonzáles-Candelas
2Institute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, 46980, Valencia, Spain
10CIBER in Epidemiology and Public Health, Spain; Joint Research Unit “Infection and Public Health” FISABIO-University of Valencia, Valencia, Spain
PhDRon Geller
2Institute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, 46980, Valencia, Spain
PhDDavid Navarro
1Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
11Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain
MDData Availability
All data produced in the present study are available upon reasonable request to the corresponding author
Posted July 19, 2022.
Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant
Jorge Camacho, Estela Giménez, Eliseo Albert, Joao Zulaica, Beatriz Álvarez-Rodríguez, Ignacio Torres, Luciana Rusu, Javier S. Burgos, Salvador Peiró, Hermelinda Vanaclocha, Ramón Limón, María Jesús Alcaraz, José Sánchez-Payá, Javier Díez-Domingo, Iñaki Comas, Fernando Gonzáles-Candelas, Ron Geller, David Navarro
medRxiv 2022.07.19.22277747; doi: https://doi.org/10.1101/2022.07.19.22277747
Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant
Jorge Camacho, Estela Giménez, Eliseo Albert, Joao Zulaica, Beatriz Álvarez-Rodríguez, Ignacio Torres, Luciana Rusu, Javier S. Burgos, Salvador Peiró, Hermelinda Vanaclocha, Ramón Limón, María Jesús Alcaraz, José Sánchez-Payá, Javier Díez-Domingo, Iñaki Comas, Fernando Gonzáles-Candelas, Ron Geller, David Navarro
medRxiv 2022.07.19.22277747; doi: https://doi.org/10.1101/2022.07.19.22277747
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2913)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12703)
- Forensic Medicine (12)
- Gastroenterology (825)
- Genetic and Genomic Medicine (4562)
- Geriatric Medicine (414)
- Health Economics (724)
- Health Informatics (2910)
- Health Policy (1068)
- Hematology (385)
- HIV/AIDS (921)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4327)
- Nursing (234)
- Nutrition (636)
- Oncology (2258)
- Ophthalmology (642)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (496)
- Pediatrics (1196)
- Primary Care Research (494)
- Public and Global Health (6912)
- Radiology and Imaging (1522)
- Respiratory Medicine (914)
- Rheumatology (436)
- Sports Medicine (381)
- Surgery (484)
- Toxicology (60)
- Transplantation (210)
- Urology (178)